Kansas City Cancer Centers — Overland Park, Kansas

Kansas City Cancer Centers is a clinical research site located in Overland Park, Kansas, United States 66210.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

Kansas City Cancer Centers has participated in 5 clinical trials.

Therapeutic areas: Palmar-Plantar Erythrodysesthesia, Breast Cancer, Non-Small Cell Lung Cancer.

Sponsors: Nanometics (d.b.a. PHD Biosciences), SCRI Development Innovations, LLC, Genzyme, a Sanofi Company.

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kansas City Cancer Centers?

Kansas City Cancer Centers has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kansas City Cancer Centers conducted?

Kansas City Cancer Centers has 5 clinical trials on record. Their work covers Palmar-Plantar Erythrodysesthesia, Breast Cancer, Non-Small Cell Lung Cancer.

Is Kansas City Cancer Centers accredited by Crixeo Health?

Kansas City Cancer Centers has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Kansas City Cancer Centers?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.